Publicação científica trimestral do CREMERJ - número 3 - 2022

111 Med. Ciên. e Arte , Rio de Janeiro, v.1, n.3, p.105-111, jul-set 2022 Características do paciente alérgico Luiz Werber-Bandeira et al. 7. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.: Allergy. 2014; 69: 1026-1045. 8. Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol. 2012; 129(3 Suppl): S9–S23. 9. Burrows B, Martinez FD, Cline MG, Lebowitz MD. The relationship between parental and children’s serum IgE and asthma. Am J Respir Crit Care Med.1995; 152(5 Pt 1):1497-1500. 10. Pillai P, Chan YC, Wu SY, Ohm-Laursen L, Thomas C, Durham SR et al. Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma. Eur Respir. 2012; J 48(6):1593-1601. 11. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma more similarities than differences. Immunol Today.1999; 20:528-33. 12. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007; 119:1043-52.